Latest Drotrecogin alfa Stories
The DrugRisk Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news.
Severe sepsis, a body’s dangerous defensive response against an infection, not only diminishes the quality of life for patients – it puts their spouses at a greater risk of depression.
A drug used to treat sepsis that was once pulled for poisoning the blood, may be effective after all. The drug, known as drotrecogin alfa (activated) was approved for use in the United States in 2001, and in Europe in 2002, on the basis of the randomized, double-blind, placebo-controlled PROWESS study.
A recent study led by researchers at Boston University School of Medicine (BUSM) shows an increased risk of stroke and mortality among patients diagnosed with severe sepsis and new-onset atrial fibrillation (AF) during hospitalization.
A new drug commonly used to treat bleeding events in people with severe hemophilia can also be used to prevent such events from happening at all, according to this study.
- A serpent whose bite was fabled to produce intense thirst.